Ajanta Pharma - At Turnaround Levels with Sound Fundamentals

17 окт. 2017 г.

It has been observed that the price action was deeply pushed down without much change in the fundamentals of the company. It may just be called as healthy correction and now the correction reached to a strong support zone which has been previously tested, therefore there is high possibility that the buyers will come at current levels and will further control over the price action.

It is a debt free company with consistent operating profit margin of more than 30%.

T1- 1300
T2- 1400
SL- 1110

17 окт. 2017 г.

Сделка активна

24 окт. 2017 г.

Сделка активна